top of page

LEARNING OBJECTIVES

After completing Module 7, the learner should be able to:

   1. Identify common psychological responses to learning about T1D risk.
   2. Recognize common barriers to engaging in screening for islet autoantibodies and/or engaging in early-stage T1D
       monitoring programs.

   3. Describe strategies for addressing needle anxiety.

Psychological Impact and Engagement

07 |

Module Authors: Holly O'Donnell, Cristy Geno

Three Conceptual Categories for Considering the Psychological Impact of T1D Risk Discussions:
          COGNITIVE          
understanding of T1D risk
  • It is challenging for people to understand their risk (or their child’s risk) for developing a disease like T1D.
     

  • Individuals from racial and ethnic minority backgrounds and fathers
    (in comparison to mothers) are
    more likely to underestimate risk.

     

  • It is important to repeatedly review risk with families to maintain accurate understanding over time.
     

  • Accurate understanding is critical for appropriate monitoring behaviors and preparation for eventual symptomatic Stage 3 T1D. 
     

  • Underestimating risk is associated with increased likelihood of withdrawal from monitoring.(1-3)
     

EMOTIONAL
response to learning about T1D risk

Parents of children WITH increased genetic risk (family history, genetic risk markers) experience anxiety regarding risk of developing T1D:

  • At high levels after learning their child is at increased genetic risk for T1D, but anxiety declines over time if there are no positive islet autoantibody tests.

  • If their child develops multiple positive islet autoantibodies, anxiety increases and this anxiety remains high over
    time
    .
    (4)
     

Parents of children WITHOUT known genetic risk:

  • Most (70%) are anxious after learning their child has tested positive for one or more antibodies. We do not yet know how this may change over time.(5)
     

Children old enough to report their own anxiety about T1D:

  • Report elevated levels of anxiety as well (36-70%), depending on factors such as age and risk category.
     

BEHAVIORAL
response to learning about T1D risk
  • Although families are told there is no proven behavior intervention to modify risk of T1D, many people will engage
    in behaviors to try to prevent T1D after learning they (or their child) are at increased risk.

     

  • It is important to monitor for behavior changes, especially diet changes
    (e.g., very low carbohydrate diet) as these can have adverse effects when taken to extremes.

Needle Anxiety

Anxiety surrounding needles and vaccination is a common experience of childhood. About 30 to 40% of children and adolescents living with type 1 diabetes experience anxiety around needles and 10-30% experienced fear of finger stick blood glucose checks.(6-8​) Mothers reporting fear and distress regarding administrating finger sticks has been reported to be about 40-50% at diagnosis and 14% at 6 to 9 months after diagnosis.(8) These barriers have also been observed in families being monitored for early-stage T1D and can present a barrier to both lab evaluation as well as engagement with home glucose testing.

        A variety of psychological interventions have been examined to help with needle-related procedural pain and distress in the pediatric age group. A Cochran review concluded that distraction and hypnosis have been shown to be effective, while other interventions including preparation with information, parent coaching, combined cognitive behavioral therapy and virtual reality require further research.(9)

​

Engagement, Coping and Barriers to Follow-Up

Many people perceive T1D as threatening, unpredictable, and uncontrollable. Thus, some individuals may respond to information about increased risk with avoidance or denial. Others may feel empowered with their new health information.

        Health care professionals should have a low threshold for referring patients experiencing anxiety or other mood concerns to a behavioral health professional, especially since waitlists for such services are long. Clinicians with training in health psychology or behavioral medicine may be a particularly good fit given their experience working with families coping with medical conditions.

        The benefits of monitoring children with presymptomatic T1D have been shown, and thus families are encouraged to participate in ongoing monitoring and follow-up. However, families must choose their level of engagement. Lack of monitoring in the context of knowledge of high risk for developing T1D is not currently considered to constitute medical neglect. The medical team can best support engagement by addressing both practical and psychosocial barriers to care.

​

Resources

Recognizing that mental health support is a major health need for children and families living with chronic conditions, the American Board of Pediatrics has developed the Roadmap Project to support the resilience and emotional health of pediatric patients with chronic conditions, their families, and the medical teams who care for them.(10)

TheRoadmapProject_IntroImage.png

The Society of Clinical Child & Adolescent Psychology has resources for parents and caregivers to find available resources for child therapy.(11)

SCCAP53.jpg

Finally, the Ask the Experts program can provide consultation with a psychologist experienced in working with families with early-stage T1D.(12)

EXPERTS-LOGO.png
REFERENCES

1.  Diabetes in the Young (TEDDY) Study: Predictors of Early Study Withdrawal
     Among Participants with No Family History of Type 1 Diabetes. Pediatr Diabetes
     2011;12(3PT1):165–71.

2.  Johnson SB, Lynch KF, Lee H-S, et al. At high risk for early withdrawal: using a
     cumulative risk model to increase retention in the first year of the TEDDY study. J
     Clin Epidemiol 2014;67(6):609–11.

3.  Johnson SB, Lynch KF, Baxter J, et al. Predicting Later Study Withdrawal in
     Participants Active in a Longitudinal Birth Cohort Study for 1 Year: The TEDDY
     Study. J Pediatr Psychol 2016;41(3):373–83.

4.  Johnson SB, Lynch KF, Roth R, Schatz D, TEDDY Study Group. My Child Is
     Islet Autoantibody Positive: Impact on Parental Anxiety. Diabetes Care
     2017;40(9):1167–72.

5.  O’Donnell HK, Rasmussen CG, Dong F, et al. Anxiety and Risk Perception in
     Parents of Children Identified by Population Screening as High Risk for Type 1
     Diabetes. Diabetes Care 2023;46(12):2155–61.

6.  Cemeroglu AP, Can A, Davis AT, et al. Fear of needles in children with type 1
     diabetes mellitus on multiple daily injections and continuous subcutaneous
     insulin infusion. Endocr Pract Off J Am Coll Endocrinol 
Am Assoc Clin Endocrinol
     2015;21(1):46–53.

7.  Simmons JH, McFann KK, Brown AC, et al. Reliability of the Diabetes Fear of
     Injecting and Self-Testing Questionnaire in pediatric patients with type 1
     diabetes. Diabetes Care 2007;30(4):987–8.

8.  Howe CJ, Ratcliffe SJ, Tuttle A, Dougherty S, Lipman TH. Needle Anxiety in
     Children With Type 1 Diabetes and Their Mothers. MCN Am J Matern Nurs
     2011;36(1):25.

9.  Uman LS, Birnie KA, Noel M, et al. Psychological interventions for needle-
     related procedural pain and distress in children and adolescents. Cochrane
     Database Syst Rev 2013;(10):CD005179.

10.Roadmap For Emotional Health [Internet]. Roadmap Emot. Health. [cited 2023
     Dec 9]; Available from: https://www.roadmapforemotionalhealth.org

11.Effective Child Therapy - By the Society of Clinical Child & Adolescent
     Psychology [Internet]. Eff. Child Ther. [cited 2023 Dec 9]; Available from:
     https://effectivechildtherapy.org/

12.Home | Ask the Experts – Early T1D Answers and Guidance [Internet].
     AsktheExperts. [cited 2023 Dec 9]; Available from:
     https://www.asktheexperts.org

This program was developed independently
by the Barbara Davis Center for Diabetes and supported in part by a grant from Sanofi US.

LOGO-banner2.png

Version 3.0_8.2025  /  Design/Website: GSU

bottom of page